Tempus AI, Inc. Class A Share Price

Tempus AI Inc. is a precision medicine technology company that leverages artificial intelligence to personalize healthcare, particularly in oncology and other critical disease areas. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon), Tempus is headquartered in Chicago and has quickly become a leader in applying AI to clinical and molecular data. Its mission is to make healthcare more data-driven by organizing and analyzing vast datasets from electronic health records, genomic sequencing, and imaging to help physicians make more informed, real-time decisions. Tempus provides both diagnostic testing services and a powerful data analytics platform that supports clinical trials, companion diagnostics, and drug discovery. The company partners with hospitals, research centers, and biopharmaceutical firms to accelerate the development of targeted therapies. With a growing presence in AI-driven diagnostics and therapeutics, Tempus is transforming how precision medicine is practiced, aiming to improve outcomes and reduce the trial-and-error nature of current treatment models.